The $3.66 Billion Case for Smarter Sterilization

Digital traceability demands are driving the sterilization monitoring market from $1.89B to $3.66B by 2036, with Getinge and 3M leading the charge

30 Apr 2026

For decades, sterilization monitoring was little more than a paperwork exercise. A chemical indicator strip changed color, a technician signed off, and the surgical instrument was cleared for use. That era is ending, and a $3.66 billion market is rising in its place.

A market intelligence report published this April found that the global sterilization monitoring supplies sector is on track to nearly double in size by 2036, growing from $1.89 billion today. The engine driving that growth isn't a single breakthrough — it's a sustained regulatory shift rewriting the rules for how hospitals, pharmaceutical plants, and device manufacturers prove their sterilization processes actually work.

Regulators across Europe and North America are now demanding digital audit trails and instrument-level traceability, with multi-parameter data capturing time, temperature, and chemical concentration simultaneously. Paper sign-offs no longer cut it. The result is surging demand for smarter, connected monitoring tools — and a handful of companies are ready to supply them.

Getinge has built a digital ecosystem linking sterile processing departments directly to operating room scheduling systems, giving hospital managers real-time visibility into every instrument's sterilization history. 3M is extending its deep expertise in chemical and biological indicators to develop platforms that pipe data straight into hospital quality management systems. Both bets look well-timed.

The business case is hard to argue with. Healthcare-associated infections cost European health systems billions annually. Digital monitoring cuts instrument retrieval errors, supports accreditation reviews, and enables predictive maintenance across sterilization infrastructure. For procurement teams navigating EU MDR requirements, generating a complete sterilization audit trail on demand is fast becoming a baseline expectation, not a premium feature.

Headwinds exist. Budget constraints in smaller hospitals across Eastern and Southern Europe are slowing adoption of premium systems. Regulatory inconsistencies among EU member states create friction for vendors operating across borders. Progress won't be uniform.

Still, the direction is unmistakable. As infection control standards tighten and digital integration becomes standard hospital infrastructure, sterilization monitoring is graduating from a back-office compliance task to a front-line patient safety tool. The market is catching up to what the stakes have always demanded.